Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains
Open Access
- 14 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (6) , e0009482
Abstract
Background: Burkholderia pseudomallei is an environmental gram-negative bacterium that causes the disease melioidosis and is endemic in many countries of the Asia-Pacific region. In Australia, the mortality rate remains high at approximately 10%, despite curative antibiotic treatment being available. The bacterium is almost exclusively found in the endemic region, which spans the tropical Northern Territory and North Queensland, with clusters occasionally present in more temperate climates. Despite being endemic to North Queensland, these infections remain understudied compared to those of the Northern Territory. Methodology/Principal findings: This study aimed to assess the prevalence of central nervous system (CNS) disease associated variant bimABm, identify circulating antimicrobial resistance mutations and genetically distinct strains from Queensland, via comparative genomics. From 76 clinical isolates, we identified the bimABm variant in 20 (26.3%) isolates and in 9 (45%) of the isolates with documented CNS infection (n = 18). Explorative analysis suggests a significant association between isolates carrying the bimABm variant and CNS disease (OR 2.8, 95% CI 1.3–6.0, P = 0.009) compared with isolates carrying the wildtype bimABp. Furthermore, 50% of isolates were identified as novel multi-locus sequence types, while the bimABm variant was more commonly identified in isolates with novel sequence types, compared to those with previously described. Additionally, mutations associated with acquired antimicrobial resistance were only identified in 14.5% of all genomes. Conclusions/Significance: The findings of this research have provided clinically relevant genomic data of B. pseudomallei in Queensland and suggest that the bimABm variant may enable risk stratification for the development CNS complications and be a potential therapeutic target.Keywords
All Related Versions
Funding Information
- European Society of Clinical Microbiology and Infectious Diseases
This publication has 34 references indexed in Scilit:
- Neurologic MelioidosisThe American Journal of Tropical Medicine and Hygiene, 2013
- Glanders: an overview of infection in humansOrphanet Journal of Rare Diseases, 2013
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Actin-Based Motility of Burkholderia thailandensis Requires a Central Acidic Domain of BimA That Recruits and Activates the Cellular Arp2/3 ComplexJournal of Bacteriology, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Prevalence and Sequence Diversity of a Factor Required for Actin-Based Motility in Natural Populations of Burkholderia SpeciesJournal of Clinical Microbiology, 2008
- Genetic Diversity of Burkholderia pseudomallei Isolates in AustraliaJournal of Clinical Microbiology, 2008
- Identification of a bacterial factor required for actin‐based motility of Burkholderia pseudomalleiMolecular Microbiology, 2005
- Melioidosis epidemiology and risk factors from a prospective whole‐population study in northern AustraliaTropical Medicine & International Health, 2004
- Endemic Melioidosis in Tropical Northern Australia: A 10‐Year Prospective Study and Review of the LiteratureClinical Infectious Diseases, 2000